HLA-G and rheumatoid arthritis: The role of HLA-G in the pathology of RA has so far almost exclusively been investigated in the early phase of RA pointing to the fact that soluble HLA-G (sHLA-G) levels will be up-regulated by the patient’s response to disease modifying anti-rheumatic drug (DMARD) therapy [22–24].